10-Q quarterly report · filed Oct 29, 2026

MERIT MEDICAL SYSTEMS INC (MMSI) Q3 2026 10-Q Quarterly Report

Short answer

MERIT MEDICAL SYSTEMS INC (MMSI) filed its Q3 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $416M (up 8.4% year over year) with net income of $42M.

Q3 2026 key financials · XBRL

Revenue
$416M
+8.4% YoY · −0.6% QoQ
Net income
$42M
+52.4% YoY · +9.0% QoQ
Operating margin
14.1%
Gross margin
48.2%
EPS (diluted)
$0.70
+52.2% YoY · +7.7% QoQ

Source: XBRL data from the MERIT MEDICAL SYSTEMS INC (MMSI) Q3 2026 10-Q on SEC EDGAR. USD.

MERIT MEDICAL SYSTEMS INC Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $416.2M, up 8.4% YoY from $384.2M
  • Net margin 10.2% vs 7.2%; operating margin 14.1% vs 11.1% YoY
  • Best platform Endoscopy, $23.4M, up 32.9%; worst Procedural Solutions, $27.2M, down 15.9%
  • Cash $505.8M vs $448.5M; operating cash flow $175.2M vs $198.9M
  • View Point sales launched; 2026 capital spending expected at $60M to $70M, with supply delays and tariff risks തുടര

Risk Factors

  • Newly added geopolitical risk: U.S.-Israel-Iran conflict escalation threatens energy supplies, supply chains, and petroleum-based input costs
  • Most materially updated financial risk: $700 million revolving commitment may increase leverage-covenant pressure and reduce cash for operations
  • Debt compliance risk: covenant breach could accelerate $747.5 million of 3.00% Convertible Notes due 2029
  • Operational risk: higher resin and petroleum-based material costs from disrupted global energy markets
  • Liquidity risk: secured-credit-agreement default could trigger collateral foreclosure and impair capital-expenditure funding

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other MERIT MEDICAL SYSTEMS INC quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.